Roche's Pharma Day 2020
Roche has hosted a virtual event on Monday, 14 September 2020.
Keynote Presentations
| Topic | Presenter | Presentation |
|---|---|---|
| Welcome | Karl Mahler, Head of Investor Relations and Roche Group Planning | |
| Pharma Strategy: Sustainable growth, more patient benefits, and less cost to society | Bill Anderson, Chief Executive Officer Roche Pharmaceuticals | |
| Commercial Opportunities | Teresa Graham, Head of Pharma Global Product Strategy | |
| Late Stage Pipeline Oncology & Non-malignant Hematology | Levi Garraway, Chief Medical Officer and Head Global Product Development | |
| Late Stage Pipeline Neuroscience | Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development | |
| Late Stage Pipeline Immunology & Ophthalmology | Cristin Hubbard, Head I2O (Immunology, Infectious Diseases, Ophthalmology) Global Product Strategy | |
| Infectious Disease: A close look at the HBV pipeline | John Young, Global Head of Infectious Diseases, Roche Pharma Research & Early Development | |
| Late Stage Infectious Diseases: Influenza & SARS-CoV-2 | Cristin Hubbard, Head I2O (Immunology, Infectious Diseases, Ophthalmology) Global Product Strategy |
| Appendix | Presentation |
|---|---|
| Pipeline overview | |
| Patient populations |
Webinar Replay
Investors